骨髓质疏松症候群管理的进展和挑战

Jessica M Stempel1, Tariq Kewan1, Amer M Zeidan1

  • 1Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, Yale Comprehensive Cancer Center, New Haven, CT 06510, USA.

Cancers
|August 14, 2025
PubMed
概括

肌肉发育综合征 (MDS) 的治疗正在变得个性化,使用新的风险工具和新型药物,如luspatercept和imetelstat用于低风险的MDS. 高风险的MDS仍然依赖于低甲基化剂,研究重点是早期检测和预防.